Matica Biotechnology, Inc. (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral vector production, and Cirsium Biosciences ("Cirsium"), a ...

Developed in collaboration with Korea's top clinical and hospital network, the integrated platform combines globally ...

Parks will spearhead development and execution of Matica Bio’s commercial strategic initiatives as EVP of Commercial Operations Sugrue to advance business development goals, partnerships as VP of ...

Matica Biotechnology, the US subsidiary of CHA Biotech, said Wednesday it had launched its Matica Open Access Platform, with ...

COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica Biotechnology, Inc. (Matica Bio), a contract development and manufacturing organization (CDMO) specializing in the GMP production of cell and gene ...

Matica Biotechnology, local firm Cha Biotech’s US subsidiary, has set out a goal of posting 1 trillion won ($761 million) in annual sales to become a global top five contract development and ...

CHA Biotech said on the 3rd that its U.S. subsidiary Matica Biotechnology signed a CDMO (contract development and manufacturing) deal with Kalidi Biotherapeutics. Kalidi develops oncolytic virus ...

Matica Biotechnology, a CDMO specializing in viral vector manufacturing for cell and gene therapies, reports that it signed a strategic commercial manufacturing agreement with a clinical-stage biotech ...

Kim to oversee cell and gene therapy (CGT) manufacturing operations, processes, operations, and business strategy as CEO during period of rapid expansion across US and Korea COLLEGE STATION, ...

Matica Biotechnology, a U.S. affiliate of Korea’s CHA Biotech, said Tuesday that it has signed a contract development and manufacturing deal with Cirsium Biosciences, a U.S. biotech firm developing ...